Brain Stimulation (Nov 2020)
Strategies to mitigate impacts of the COVID-19 pandemic on patients treated with deep brain stimulation
- Kristin Kostick,
- Eric A. Storch,
- Peter Zuk,
- J.S. Blumenthal-Barby,
- Laura Torgerson,
- Daniel Yoshor,
- Sameer Sheth,
- Ashwin Viswanathan,
- Arjun Tarakad,
- Joohi Jimenez-Shahed,
- Wayne Goodman,
- Gabriel Lázaro-Muñoz
Affiliations
- Kristin Kostick
- Corresponding author.; Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA
- Eric A. Storch
- Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA
- Peter Zuk
- Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA
- J.S. Blumenthal-Barby
- Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA
- Laura Torgerson
- Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA
- Daniel Yoshor
- Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA
- Sameer Sheth
- Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA
- Ashwin Viswanathan
- Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA
- Arjun Tarakad
- Parkinson’s Disease and Movement Disorders Center, Neurology, Movement Disorders, Baylor College of Medicine, Houston, TX, USA
- Joohi Jimenez-Shahed
- Movement Disorders Neuromodulation & Brain Circuit Therapeutics, Neurology, Icahn School of Medicine at Mount Sinai, Mount Sinai West, 1000 10th Avenue, Suite 10C, New York, NY, 10019, USA
- Wayne Goodman
- Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA
- Gabriel Lázaro-Muñoz
- Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA
- Journal volume & issue
-
Vol. 13,
no. 6
pp. 1642 – 1643